Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research focused on Mendelian randomization and Computational biology, with related work in Pharmacovigilance, Drug, Gene. Notable publications include 'Potential drug targets for myocardial infarction identified through Mendelian randomization analysis and Genetic colocalization', 'Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis', and 'Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance'.
Integrated bioinformatics and network search identify biomarkers and comorbid mechanisms of atrial fibrillation and ischemic stroke
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis
Identification of steroid-induced osteonecrosis of the femoral head biomarkers based on immunization and animal experiments
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation
Application of superb microvascular imaging technology in clinical disease activity of rheumatoid arthritis
Letter to the Editor: Discussion on the suicide risk of CCB drugs: based on real-world drug safety surveillance
Potential drug targets for myocardial infarction identified through Mendelian randomization analysis and Genetic colocalization